Johnson & Johnson (JNJ)
NYSE: JNJ · IEX Real-Time Price · USD
146.14
-0.68 (-0.46%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Johnson & Johnson Revenue

In the year 2023, Johnson & Johnson had annual revenue of $85.16B with 6.46% growth. Revenue in the quarter ending December 31, 2023 was $13.53B with 7.84% year-over-year growth.

Revenue (ttm)
$85.16B
Revenue Growth
+6.46%
P/S Ratio
4.14
Revenue / Employee
$645,633
Employees
131,900
Market Cap
352.17B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B3.02B4.23%
Dec 29, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B5.49B13.10%
Dec 28, 200341.86B5.56B15.33%
Dec 29, 200236.30B3.98B12.32%
Dec 30, 200132.32B3.15B10.78%
Dec 31, 200029.17B1.17B4.16%
Dec 30, 199928.01B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Merck & Co. 60.12B
AbbVie 54.32B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Eli Lilly 34.12B
Revenue Rankings